137 related articles for article (PubMed ID: 917012)
1. C5-dependent enhancement of rosette formation and phagocytosis by human polymorphonuclear leukocytes.
Segerling M; Opferkuch W
Monogr Allergy; 1977; 12():101-4. PubMed ID: 917012
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
3. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
Hammer CH; Hänsch G; Gresham HD; Shin ML
J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
[TBL] [Abstract][Full Text] [Related]
4. IgG and C3 receptors on polymorphonuclear leukocytes in phagocytosis. Role of C3-receptors in the attachment and ingestion phases.
Capsoni F; Caredda F; Borzini P; Lazzarin A
Boll Ist Sieroter Milan; 1977 Nov; 56(5):442-8. PubMed ID: 597396
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte complement: a possible role for C5 in lymphocyte stimulation.
Sundsmo JS
J Immunol; 1983 Aug; 131(2):886-91. PubMed ID: 6223096
[TBL] [Abstract][Full Text] [Related]
6. Human monocyte spreading induced by activated factor B of the complement alternative pathway: differential effects of Fab' and F(ab')2 antibody fragments directed to C5, C6, and C7.
Sundsmo JS; Götze O
Cell Immunol; 1983 Apr; 77(1):176-86. PubMed ID: 6601526
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.
Biesecker G; Gomez CM
J Immunol; 1989 Apr; 142(8):2654-9. PubMed ID: 2703710
[TBL] [Abstract][Full Text] [Related]
8. Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.
Nemerow GR; Gewurz H; Osofsky SG; Lint TF
J Clin Invest; 1978 Jun; 61(6):1602-10. PubMed ID: 350902
[TBL] [Abstract][Full Text] [Related]
9. The release of C5a in complement-activated serum does not require C6.
Biesecker G; Wagner JL; Hugli TE
J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
[TBL] [Abstract][Full Text] [Related]
10. Freeze-thaw activation of the complement attack phase: I. Separation of two steps in the formation of the active C--56 complex.
Dessauer A; Rother U; Rother K
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():75-81. PubMed ID: 6587745
[TBL] [Abstract][Full Text] [Related]
11. Terminal complement components play a role in the expression of C5a.
Gresham HD; Renfer L; Hammer CH; Frank MM
J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
[TBL] [Abstract][Full Text] [Related]
12. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
[TBL] [Abstract][Full Text] [Related]
13. Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation.
Høgåsen AK; Würzner R; Abrahamsen TG; Dierich MP
J Immunol; 1995 May; 154(9):4734-40. PubMed ID: 7722325
[TBL] [Abstract][Full Text] [Related]
14. Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.
Reed WP
Immunology; 1975 Jun; 28(6):1051-9. PubMed ID: 1132888
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.
Blaser MJ; Smith PF; Repine JE; Joiner KA
J Clin Invest; 1988 May; 81(5):1434-44. PubMed ID: 3366901
[TBL] [Abstract][Full Text] [Related]
16. Proteolysis of the C5b-7 complex: cleavage of the C5b and C6 subunits and its effect on the interaction of the complex with phospholipid bilayers.
Yamamoto KI
J Immunol; 1980 Oct; 125(4):1745-50. PubMed ID: 6997387
[TBL] [Abstract][Full Text] [Related]
17. [Participation of polymorphonuclear leukocytes in basic defensive mechanisms].
Chabior M; Baranowska B; Kozłowski M
Pediatr Pol; 1981 Mar; 56(3):327-33. PubMed ID: 7019835
[No Abstract] [Full Text] [Related]
18. Moculating effect of the late-acting components of the complement system on the bactericidal activity of human polymorphonuclear leukocytes on E. coli 0111:B4.
Tedesco F; Rottini G; Patriarca P
J Immunol; 1981 Nov; 127(5):1910-5. PubMed ID: 7028865
[TBL] [Abstract][Full Text] [Related]
19. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
[TBL] [Abstract][Full Text] [Related]
20. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
Håkansson L; Hällgren R; Venge P
Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
